Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Recruiting 4Terminated 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Other 1

Conditions

Endometrial Neoplasms 4Endometrial Hyperplasia 2Obesity 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Progestins × Clear all
NCT06914297 2026-06-04

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

Fudan University

Phase 2 Recruiting
10 enrolled
Gynecologic

Endometrial Neoplasms

NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting
1,615 enrolled
Gynecologic

Endometrial Neoplasms

NCT07377734 2026-03-30

2026ColECFerSp

Peking University People's Hospital

Phase 2 Recruiting
30 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT05903131 2026-01-20

Uterine Preservation Via Lifestyle Transformation

Washington University School of Medicine

Phase 2 Recruiting
96 enrolled
GynecologicOther

Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡